# War Room Findings

Overnight research results compiled by isolated cron jobs.  
Morning briefing reads this file to assemble intel section.

---

## 2026-02-05 - Competitor Intelligence

**MiMedx - Major Partnership Announcement (Feb 4, 2026)**
- Entered exclusive distribution agreement with Summit Products Group
- Adding 3 new 510(k)-cleared products: Hydrelix, NovaForm, G4Derm Plus
- Complements existing Surgical & Wound portfolio
- Source: Globe Newswire, announced yesterday

**MiMedx - Analyst Downgrade on CMS Confusion**
- Craig-Hallum lowered near-term volume expectations
- Expects provider confusion from CMS LCD withdrawal to pressure Q1 2026 volumes
- Forecasting single-digit sequential growth in Q1 (down from prior expectations)
- Extended timeline for anticipated market share gains
- Source: Yahoo Finance, 2 days ago

**Integra LifeSciences - Aggressive CMS Positioning**
- CEO Mojdeh Poul statement: "No other company offers this breadth of cost-effective wound reconstruction solutions"
- Positioning their diverse portfolio as uniquely aligned to CMS reimbursement changes
- Emphasizing clinical evidence and uniform reimbursement across care settings
- Competitive messaging targeting market leadership post-CMS reform

**Smith+Nephew - 2026 Growth Acceleration**
- Expects approximately 6% underlying revenue growth in 2026 (up from 5% in 2025)
- Targeting 6-7% CAGR by 2028
- December 2025 investor update following turnaround success
- Source: Reuters

**Organogenesis - Industry Visibility Push**
- Principal Partner sponsor for WCCC Driving Innovation Summit at 2026 SAWC Spring
- Promoting CYGNUS Dual (dual-layered amniotic membrane product)
- Maintaining high industry event visibility

---

## 2026-02-05 - CMS Regulatory Intelligence

**CMS Final Rule 2026 - First Physician Payment Increase in 5 Years**
- Medicare conversion factor increases: $33.57 for QPs (3.77% increase), $33.40 for non-QPs (3.26% increase)
- Previous rate: $32.35 for both (2025)
- Positive signal for provider financial health - may support broader adoption of advanced wound care
- Source: CMS Final Rule CY 2026 (finalized Oct 31, 2025, effective Jan 1, 2026)

**Medicare Prior Authorization Reforms**
- 7-day response time mandate for prior authorizations on all Medicare Advantage plans (2026)
- FHIR APIs required for patient access, provider access, prior authorization, payer-to-payer (technical compliance by Jan 1, 2027)
- Could reduce delays in skin substitute approvals for MA patients
- Source: CMS Final Rule 2026

**Telehealth Expansion - Permanent Virtual Supervision**
- Virtual supervision now permanent for most services (excluding some surgical procedures)
- Expanded telehealth codes added to Medicare Telehealth Services List
- Frequency limits eliminated for inpatient/nursing facility visits
- Opportunity: Telehealth wound care consults may increase access to specialists

**Practice Expense Methodology Changes**
- Higher indirect cost recognition for office-based vs facility-based providers
- Hospital data (OPPS) now used to set rates for some PFS services
- May affect wound care clinic reimbursement models

**WISeR Model Rollout - Prior Authorization Scrutiny**
- CMS "Wasteful and Inappropriate Service Reduction" model under provider scrutiny
- Designed to root out wasteful spending in fee-for-service Medicare
- Implementation timeline and wound care impact unclear - monitor for updates
- Source: Modern Healthcare (Jan 29, 2026)

---
